Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.
Belanoff et al. • 2011 • Eur J Pharmacol. 2011;655(1-3):117-20.
© 2024 Corcept Therapeutics, Incorporated
The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
Beebe et al. • 2006 • Behav Brain Res. 2006;171(2):225-9.
Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.
Gross et al. • 2010 • Obesity (Silver Spring). 2010;18(12):2295-300.
Mifepristone treatment of olanzapine-induced weight gain in healthy men.
Gross et al. • 2009 • Adv Ther. 2009;26(10):959-69.
The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness.
Moraitis et al. • 2017 • J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):114-120.